Lund Pharma AB

Active
559378-4472Limited company (AB)Registered 2022LUND

Key figures

10 691 787 kr+89,6%
Revenue 2023
+89,6%
Average annual growth 2022–2023
05 m10 m15 m20222023

Key figures

2023

Summary: Lund Pharma AB

What kind of company is it?

Lund Pharma AB (org. no. 559378-4472) is a limited company (AB). The company was registered in 2022 and has existed for 4 years. Registered seat: Lund. Industry according to Statistics Sweden: retail sale of pharmaceutical products in specialised stores (SNI 47731).

How is the company doing financially?

Net sales in financial year 2023 were 10 691 787 kr, up 89,6 % on the previous year (5 638 666 kr). Net profit for 2023 was 303 370 kr (2,8 % of net sales). Employees in financial year 2023: 3. Net sales per employee were 3 563 929 kr. At the end of financial year 2023, total assets were 2 637 911 kr and equity 676 973 kr (equity ratio 25,7 %). The annual report for 2023 proposes a dividend of 463 000 kr.

What should you look out for?

The latest digitally filed annual report is for 2023.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2023

Proposed dividend 463 000 kr.

Summary of annual reports2022–2023
20222023
Sales revenue5 638 66610 691 787
Profit for the reporting year348 603303 370
Retained earnings of previous periods——
Total assets2 358 8272 637 911
Total liabilities1 985 2241 960 938
Total equity373 603676 973
Employees33
Proposed dividend—463 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Similar companies